Choose language

Africro Increasing access to clinical trials and quality healthcare using Ai

Cover image of Africro, Biotechnology and medical research venture on VC4A

Involvement in clinical trials gives patients access to the safest, most innovative medicines in the market, yet, only 2% of clinical trials are performed in Africa. This lack of diversity in clinical trials is costing billions of dollars a year in early deaths & poor health.
This is partly due to lack of education and access to clinical trials in Africa. Many Africans live far from clinics, hospitals, labs & pharmacies and have limited access to clinical trials.
Our mission is to connect African patients to the safest, most effective innovative medical interventions on the market, by inclusion in clinical trials. Although Africans bear 25% of the disease burden, only 2% of clinical trials are performed there. We are building an Ai- & block-chain- enabled tripartite platform (including a patient online app) to improve patient access, engagement & retention, and enhance efficiencies across the clinical trial process in an unprecedented manner & for all study sta

SectorsBiotechnology and medical research, Healthcare providers and services, Pharmaceuticals
LocationLekki, Nigeria
StageSign in to view details
MarketsSign in to view details
Customer modelSign in to view details
ContactSign in to view details
Social media